← Back to Search

Category 1 (biospecimens, surveys, interviews) for Cancer (PE-CGS Trial)

N/A

Recruiting

Led By Cheryl Willman, MD

Research Sponsored by New Mexico Cancer Care Alliance

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

The PE-CGS Research Center is only recruiting and sequencing tumors for adult-onset cancers (patients and survivors) among the American Indian Tribes, Nations, and Pueblos of New Mexico and adjacent states

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 18 months

Awards & highlights

PE-CGS Trial Summary

This trial is looking at ways to recruit American Indians from Southwestern Tribal Nations for cancer genome sequencing. American Indians in this region have higher rates of certain types of cancer, and they may also have shorter

Who is the study for?

This trial is for adult American Indians from Southwestern Tribal Nations who have cancer or are survivors. Participants must be adults able to consent, self-identify as American Indian, and belong to tribes in New Mexico or nearby states. It excludes those cognitively impaired, unable to consent, not yet adults, or prisoners.Check my eligibility

What is being tested?

The study is exploring how best to engage American Indians of the Southwest in cancer genome sequencing. It involves survey administration, returning results to participants, and collecting biospecimens like tissue samples from tumors.See study design

What are the potential side effects?

Since this trial does not involve drugs but rather surveys and sample collection, there are no direct side effects related to medications. However, participants may experience discomfort or emotional distress during sample collection or upon receiving personal genetic information.

PE-CGS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am an adult cancer patient or survivor from an American Indian community in New Mexico or nearby.

PE-CGS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Biospecimen participation rate

Data participation rate

Rate of Preparatory and Optimization Phase completion

+4 more

PE-CGS Trial Design

1Treatment groups

Experimental Treatment

Group I: Category 1 (biospecimens, surveys, interviews)Experimental Treatment3 Interventions

Cancer patients and survivors undergo collection of tissue, blood, saliva, and stool samples on study for genomic sequencing and microbiome analysis. Cancer patients and survivors also complete surveys and interviews on study pre and post intervention.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Biospecimen Collection

2004

Completed Phase 2

~1700

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

New Mexico Cancer Care AllianceLead Sponsor

70 Previous Clinical Trials

51,466 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,668 Previous Clinical Trials

40,925,285 Total Patients Enrolled

Cheryl Willman, MDPrincipal InvestigatorUniversity of New Mexico Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for potential participants in this research study?

"Indeed, the information available on clinicaltrials.gov indicates that this particular clinical trial is actively seeking eligible participants. The trial was originally posted on March 22nd, 2022 and was most recently updated on January 5th, 2024. In total, the study aims to enroll 1001 individuals at a single research site."

Answered by AI

What is the current number of participants being admitted into this clinical study?

"Indeed, as stated on clinicaltrials.gov, this trial is actively seeking eligible candidates. The initial posting of the trial occurred on March 22nd, 2022 and it was last updated on January 5th, 2024. This study aims to recruit a total of 1001 participants from a single designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing

2022. "Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06207864.

All > Albuquerque